[조사자료] 글로벌 페니실린 시장 2023-2027 : 경구제, 비경구제

■ 영문 제목 : Global Penicillin Market 2023-2027
	■ 상품코드 : IRTNTR40093-23 ■ 조사/발행회사 : Technavio ■ 발행일 : 2023년 8월 ■ 페이지수 : 약120 ■ 작성언어 : 영문 ■ 보고서 형태 : PDF ■ 납품 방식 : E메일 (주문후 24시간내) ■ 조사대상 지역 : 글로벌 ■ 산업 분야 : 의료

■ 판매가격 / 옵션 (부가세 10% 별도)

Single User (1인 열람용)	USD2,500 ⇒환산￦3,375,000	견적의뢰/주문/질문
Enterprise License (기업 열람용)	USD4,000 ⇒환산￦5,400,000	견적의뢰/주문/질문

※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.

글로벌 페니실린 시장 2023-2027
페니실린 시장은 2022년부터 2027년까지 2억 4,502만 달러로 성장하며, 예측 기간 동안 4.98%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 페니실린 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진 요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 담고 있습니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 시장을 주도하는 요인은 감염성 질환의 유행, 다양한 질병과 그 치료에 대한 인식 증가, 특별한 규제 지정 등이 있습니다.

Technavio사의 페니실린 시장은 다음과 같이 분류하고 있습니다.

유형별
- 경구제
- 비경구제

공급원별
- 반합성
- 천연

지역별
- 북미
- 유럽
- 아시아
- 기타 지역(ROW)

이 보고서는 향후 몇 년 동안 페니실린 시장의 성장을 촉진하는 주요 이유 중 하나로 전략적 제휴와 M&A를 꼽고 있습니다. 또한, 항생제 연구를 위한 연방 정부 및 기관에 대한 자금 지원 증가와 수혈을 통한 감염 확산 위험의 증가는 시장의 큰 수요로 이어질 것으로 예상되고 있습니다.

페니실린 시장 보고서는 다음과 같은 분야를 다루고 있습니다.
- 페니실린 시장 규모
- 페니실린 시장 예측
- 페니실린 시장 분석

이 보고서는 페니실린 시장의 주요 업체인 Abbott Laboratories, AdvaCare Pharma, Aenova Holding GmbH, Astellas Pharma Inc., Canvax Biotech SL, Cipla Ltd., F. Hoffmann La Roche Ltd., FUJIFILM Corp., GlaxoSmithKline Plc, Glenmark Pharmaceuticals Ltd., Hikma Pharmaceuticals Plc, Lupin Ltd., Merck KGaA, Novartis AG, Pfizer Inc., Recipharm AB, Sanofi, Sun Pharmaceutical Industries Ltd., Viatris Inc., 및 Wellona Pharma.등의 정보를 수록하고 있습니다. 또한, 페니실린 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것으로 예상되고 있습니다.

이 연구는 업계 주요 참가자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있으며, 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.

■ 보고서 개요

1. 개요
2. 세계의 페니실린 시장 현황
3. 세계의 페니실린 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 유형별 시장 분석
7. 출처별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Type
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Source
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global penicillin market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global penicillin market 2017 – 2021 ($ million)
o 4.2 Type Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
o 4.3 Source Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Source Segment 2017 – 2021 ($ million)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Type
o 6.1 Market segments
o Exhibit 30: Chart on Type – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Type – Market share 2022-2027 (%)
o 6.2 Comparison by Type
o Exhibit 32: Chart on Comparison by Type
o Exhibit 33: Data Table on Comparison by Type
o 6.3 Oral – Market size and forecast 2022-2027
o Exhibit 34: Chart on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 35: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
o Exhibit 36: Chart on Oral – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Oral – Year-over-year growth 2022-2027 (%)
o 6.4 Parenteral – Market size and forecast 2022-2027
o Exhibit 38: Chart on Parenteral – Market size and forecast 2022-2027 ($ million)
o Exhibit 39: Data Table on Parenteral – Market size and forecast 2022-2027 ($ million)
o Exhibit 40: Chart on Parenteral – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Parenteral – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Type
o Exhibit 42: Market opportunity by Type ($ million)
o Exhibit 43: Data Table on Market opportunity by Type ($ million)
7 Market Segmentation by Source
o 7.1 Market segments
o Exhibit 44: Chart on Source – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Source – Market share 2022-2027 (%)
o 7.2 Comparison by Source
o Exhibit 46: Chart on Comparison by Source
o Exhibit 47: Data Table on Comparison by Source
o 7.3 Semisynthetic – Market size and forecast 2022-2027
o Exhibit 48: Chart on Semisynthetic – Market size and forecast 2022-2027 ($ million)
o Exhibit 49: Data Table on Semisynthetic – Market size and forecast 2022-2027 ($ million)
o Exhibit 50: Chart on Semisynthetic – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Semisynthetic – Year-over-year growth 2022-2027 (%)
o 7.4 Natural – Market size and forecast 2022-2027
o Exhibit 52: Chart on Natural – Market size and forecast 2022-2027 ($ million)
o Exhibit 53: Data Table on Natural – Market size and forecast 2022-2027 ($ million)
o Exhibit 54: Chart on Natural – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Natural – Year-over-year growth 2022-2027 (%)
o 7.5 Market opportunity by Source
o Exhibit 56: Market opportunity by Source ($ million)
o Exhibit 57: Data Table on Market opportunity by Source ($ million)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 59: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 61: Chart on Geographic comparison
o Exhibit 62: Data Table on Geographic comparison
o 9.3 North America – Market size and forecast 2022-2027
o Exhibit 63: Chart on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
o Exhibit 65: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 66: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
o Exhibit 69: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
o Exhibit 77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 79: Chart on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 80: Data Table on US – Market size and forecast 2022-2027 ($ million)
o Exhibit 81: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 UK – Market size and forecast 2022-2027
o Exhibit 83: Chart on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 84: Data Table on UK – Market size and forecast 2022-2027 ($ million)
o Exhibit 85: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 87: Chart on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 88: Data Table on China – Market size and forecast 2022-2027 ($ million)
o Exhibit 89: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 Germany – Market size and forecast 2022-2027
o Exhibit 91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
o Exhibit 93: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.11 Canada – Market size and forecast 2022-2027
o Exhibit 95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
o Exhibit 97: Chart on Canada – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 99: Market opportunity By Geographical Landscape ($ million)
o Exhibit 100: Data Tables on Market opportunity By Geographical Landscape ($ million)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 101: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 102: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 103: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 104: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 105: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 106: Matrix on vendor position and classification
o 12.3 Abbott Laboratories
o Exhibit 107: Abbott Laboratories – Overview
o Exhibit 108: Abbott Laboratories – Business segments
o Exhibit 109: Abbott Laboratories – Key news
o Exhibit 110: Abbott Laboratories – Key offerings
o Exhibit 111: Abbott Laboratories – Segment focus
o 12.4 AdvaCare Pharma
o Exhibit 112: AdvaCare Pharma – Overview
o Exhibit 113: AdvaCare Pharma – Product / Service
o Exhibit 114: AdvaCare Pharma – Key offerings
o 12.5 Aenova Holding GmbH
o Exhibit 115: Aenova Holding GmbH – Overview
o Exhibit 116: Aenova Holding GmbH – Product / Service
o Exhibit 117: Aenova Holding GmbH – Key offerings
o 12.6 Canvax Biotech SL
o Exhibit 118: Canvax Biotech SL – Overview
o Exhibit 119: Canvax Biotech SL – Product / Service
o Exhibit 120: Canvax Biotech SL – Key offerings
o 12.7 Cipla Ltd.
o Exhibit 121: Cipla Ltd. – Overview
o Exhibit 122: Cipla Ltd. – Business segments
o Exhibit 123: Cipla Ltd. – Key news
o Exhibit 124: Cipla Ltd. – Key offerings
o Exhibit 125: Cipla Ltd. – Segment focus
o 12.8 F. Hoffmann La Roche Ltd.
o Exhibit 126: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 127: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 128: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 129: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 130: F. Hoffmann La Roche Ltd. – Segment focus
o 12.9 GlaxoSmithKline Plc
o Exhibit 131: GlaxoSmithKline Plc – Overview
o Exhibit 132: GlaxoSmithKline Plc – Business segments
o Exhibit 133: GlaxoSmithKline Plc – Key news
o Exhibit 134: GlaxoSmithKline Plc – Key offerings
o Exhibit 135: GlaxoSmithKline Plc – Segment focus
o 12.10 Glenmark Pharmaceuticals Ltd.
o Exhibit 136: Glenmark Pharmaceuticals Ltd. – Overview
o Exhibit 137: Glenmark Pharmaceuticals Ltd. – Product / Service
o Exhibit 138: Glenmark Pharmaceuticals Ltd. – Key offerings
o 12.11 Lupin Ltd.
o Exhibit 139: Lupin Ltd. – Overview
o Exhibit 140: Lupin Ltd. – Product / Service
o Exhibit 141: Lupin Ltd. – Key news
o Exhibit 142: Lupin Ltd. – Key offerings
o 12.12 Novartis AG
o Exhibit 143: Novartis AG – Overview
o Exhibit 144: Novartis AG – Business segments
o Exhibit 145: Novartis AG – Key offerings
o Exhibit 146: Novartis AG – Segment focus
o 12.13 Pfizer Inc.
o Exhibit 147: Pfizer Inc. – Overview
o Exhibit 148: Pfizer Inc. – Product / Service
o Exhibit 149: Pfizer Inc. – Key news
o Exhibit 150: Pfizer Inc. – Key offerings
o 12.14 Recipharm AB
o Exhibit 151: Recipharm AB – Overview
o Exhibit 152: Recipharm AB – Business segments
o Exhibit 153: Recipharm AB – Key offerings
o Exhibit 154: Recipharm AB – Segment focus
o 12.15 Sanofi
o Exhibit 155: Sanofi – Overview
o Exhibit 156: Sanofi – Business segments
o Exhibit 157: Sanofi – Key news
o Exhibit 158: Sanofi – Key offerings
o Exhibit 159: Sanofi – Segment focus
o 12.16 Sun Pharmaceutical Industries Ltd.
o Exhibit 160: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 161: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 162: Sun Pharmaceutical Industries Ltd. – Key offerings
o 12.17 Viatris Inc.
o Exhibit 163: Viatris Inc. – Overview
o Exhibit 164: Viatris Inc. – Business segments
o Exhibit 165: Viatris Inc. – Key news
o Exhibit 166: Viatris Inc. – Key offerings
o Exhibit 167: Viatris Inc. – Segment focus
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 168: Inclusions checklist
o Exhibit 169: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 170: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 171: Research methodology
o Exhibit 172: Validation techniques employed for market sizing
o Exhibit 173: Information sources
o 13.5 List of abbreviations
o Exhibit 174: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Type
Exhibits6: Executive Summary – Chart on Market Segmentation by Source
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ million)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ million)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global penicillin market 2017 – 2021 ($ million)
Exhibits19: Historic Market Size – Type Segment 2017 – 2021 ($ million)
Exhibits20: Historic Market Size – Source Segment 2017 – 2021 ($ million)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ million)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ million)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Type – Market share 2022-2027 (%)
Exhibits31: Data Table on Type – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits35: Data Table on Oral – Market size and forecast 2022-2027 ($ million)
Exhibits36: Chart on Oral – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Oral – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Parenteral – Market size and forecast 2022-2027 ($ million)
Exhibits39: Data Table on Parenteral – Market size and forecast 2022-2027 ($ million)
Exhibits40: Chart on Parenteral – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Parenteral – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Chart on Source – Market share 2022-2027 (%)
Exhibits45: Data Table on Source – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Source
Exhibits47: Data Table on Comparison by Source
Exhibits48: Chart on Semisynthetic – Market size and forecast 2022-2027 ($ million)
Exhibits49: Data Table on Semisynthetic – Market size and forecast 2022-2027 ($ million)
Exhibits50: Chart on Semisynthetic – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Semisynthetic – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Natural – Market size and forecast 2022-2027 ($ million)
Exhibits53: Data Table on Natural – Market size and forecast 2022-2027 ($ million)
Exhibits54: Chart on Natural – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Natural – Year-over-year growth 2022-2027 (%)
Exhibits56: Market opportunity by Source ($ million)
Exhibits57: Data Table on Market opportunity by Source ($ million)
Exhibits58: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits59: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits60: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits61: Chart on Geographic comparison
Exhibits62: Data Table on Geographic comparison
Exhibits63: Chart on North America – Market size and forecast 2022-2027 ($ million)
Exhibits64: Data Table on North America – Market size and forecast 2022-2027 ($ million)
Exhibits65: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits66: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits67: Chart on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits68: Data Table on Europe – Market size and forecast 2022-2027 ($ million)
Exhibits69: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits70: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ million)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits76: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ million)
Exhibits77: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on US – Market size and forecast 2022-2027 ($ million)
Exhibits80: Data Table on US – Market size and forecast 2022-2027 ($ million)
Exhibits81: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on UK – Market size and forecast 2022-2027 ($ million)
Exhibits84: Data Table on UK – Market size and forecast 2022-2027 ($ million)
Exhibits85: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on China – Market size and forecast 2022-2027 ($ million)
Exhibits88: Data Table on China – Market size and forecast 2022-2027 ($ million)
Exhibits89: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits92: Data Table on Germany – Market size and forecast 2022-2027 ($ million)
Exhibits93: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits96: Data Table on Canada – Market size and forecast 2022-2027 ($ million)
Exhibits97: Chart on Canada – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on Canada – Year-over-year growth 2022-2027 (%)
Exhibits99: Market opportunity By Geographical Landscape ($ million)
Exhibits100: Data Tables on Market opportunity By Geographical Landscape ($ million)
Exhibits101: Impact of drivers and challenges in 2022 and 2027
Exhibits102: Overview on Criticality of inputs and Factors of differentiation
Exhibits103: Overview on factors of disruption
Exhibits104: Impact of key risks on business
Exhibits105: Vendors covered
Exhibits106: Matrix on vendor position and classification
Exhibits107: Abbott Laboratories – Overview
Exhibits108: Abbott Laboratories – Business segments
Exhibits109: Abbott Laboratories – Key news
Exhibits110: Abbott Laboratories – Key offerings
Exhibits111: Abbott Laboratories – Segment focus
Exhibits112: AdvaCare Pharma – Overview
Exhibits113: AdvaCare Pharma – Product / Service
Exhibits114: AdvaCare Pharma – Key offerings
Exhibits115: Aenova Holding GmbH – Overview
Exhibits116: Aenova Holding GmbH – Product / Service
Exhibits117: Aenova Holding GmbH – Key offerings
Exhibits118: Canvax Biotech SL – Overview
Exhibits119: Canvax Biotech SL – Product / Service
Exhibits120: Canvax Biotech SL – Key offerings
Exhibits121: Cipla Ltd. – Overview
Exhibits122: Cipla Ltd. – Business segments
Exhibits123: Cipla Ltd. – Key news
Exhibits124: Cipla Ltd. – Key offerings
Exhibits125: Cipla Ltd. – Segment focus
Exhibits126: F. Hoffmann La Roche Ltd. – Overview
Exhibits127: F. Hoffmann La Roche Ltd. – Business segments
Exhibits128: F. Hoffmann La Roche Ltd. – Key news
Exhibits129: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits130: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits131: GlaxoSmithKline Plc – Overview
Exhibits132: GlaxoSmithKline Plc – Business segments
Exhibits133: GlaxoSmithKline Plc – Key news
Exhibits134: GlaxoSmithKline Plc – Key offerings
Exhibits135: GlaxoSmithKline Plc – Segment focus
Exhibits136: Glenmark Pharmaceuticals Ltd. – Overview
Exhibits137: Glenmark Pharmaceuticals Ltd. – Product / Service
Exhibits138: Glenmark Pharmaceuticals Ltd. – Key offerings
Exhibits139: Lupin Ltd. – Overview
Exhibits140: Lupin Ltd. – Product / Service
Exhibits141: Lupin Ltd. – Key news
Exhibits142: Lupin Ltd. – Key offerings
Exhibits143: Novartis AG – Overview
Exhibits144: Novartis AG – Business segments
Exhibits145: Novartis AG – Key offerings
Exhibits146: Novartis AG – Segment focus
Exhibits147: Pfizer Inc. – Overview
Exhibits148: Pfizer Inc. – Product / Service
Exhibits149: Pfizer Inc. – Key news
Exhibits150: Pfizer Inc. – Key offerings
Exhibits151: Recipharm AB – Overview
Exhibits152: Recipharm AB – Business segments
Exhibits153: Recipharm AB – Key offerings
Exhibits154: Recipharm AB – Segment focus
Exhibits155: Sanofi – Overview
Exhibits156: Sanofi – Business segments
Exhibits157: Sanofi – Key news
Exhibits158: Sanofi – Key offerings
Exhibits159: Sanofi – Segment focus
Exhibits160: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits161: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits162: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits163: Viatris Inc. – Overview
Exhibits164: Viatris Inc. – Business segments
Exhibits165: Viatris Inc. – Key news
Exhibits166: Viatris Inc. – Key offerings
Exhibits167: Viatris Inc. – Segment focus
Exhibits168: Inclusions checklist
Exhibits169: Exclusions checklist
Exhibits170: Currency conversion rates for US$
Exhibits171: Research methodology
Exhibits172: Validation techniques employed for market sizing
Exhibits173: Information sources
Exhibits174: List of abbreviations

※본 조사보고서 [글로벌 페니실린 시장 2023-2027 : 경구제, 비경구제] (코드 : IRTNTR40093-23) 판매에 관한 면책사항을 반드시 확인하세요.

※본 조사보고서 [글로벌 페니실린 시장 2023-2027 : 경구제, 비경구제] 에 대해서 E메일 문의는 여기를 클릭하세요.

※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!

[이하, 관련 보고서 소개]

글로벌 페니실린 의약품 시장 (2023-2032) : 천연 페니실린, 반합성 페니실린
ALD23SEP176 / Allied Market Research / 2023년 6월 / 글로벌 페니실린 의약품 시장은 2022년 84억 달러 규모였으며 2023년부터 2032년까지 3.7%의 연평균 성장률을 보이며 2032년에는 121억 달러에 달할 것으로 예상됩니다. 페니실린은 베타-락탐 항생제 계열에 속하는 항생제 그룹입니다. 이 약물은 다양한...CHAPTER 1 : 소개 CHAPTER 2 : 개요 CHAPTER 3 : 시장 동향 CHAPTER 4 : 페니실린 의약품 시장, 공급원별 CHAPTER 5 : 페니실린 의약품 시장, 투여 경로별 CHAPTER 6 : 페니실린 의약품 시장, 활성 스펙트럼별 CHAPTER 7 : 페니실린 의약품 시장, 유통 채널별 CHAPTER 8 : 페니실린 의약품 시장,...

글로벌 자율 무인 잠수정 (AUV) 시장 2023-2027 : 통신, 충돌 회피,내비게이션,추진,이미징
IRTNTR75836-23 / Technavio / 2023년 6월 / 글로벌 자율 무인 잠수정 (AUV) 시장 2023-2027년 자율 무인 잠수정 (AUV) 시장은 2022년에서 2027년까지 19억 8,504만 달러 규모로 성장하여, 예측 기간 동안 16.85%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 자율...1. 개요 2. 세계의 자율 무인 잠수정 (AUV) 시장 현황 3. 세계의 자율 무인 잠수정 (AUV) 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 기술별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13....

글로벌 불소 시장 2023-2027 : 제약 등급, 산업용 등급
IRTNTR75995-23 / Technavio / 2023년 7월 / 글로벌 불소 시장 2023-2027 불소 시장은 2022년부터 2027년까지 1억 5,105만 달러로 성장하며, 예측 기간 동안 3.85%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 불소 시장에 대한 전반적인 분석, 시장 규모와 예측,...1. 개요 2. 세계의 불소 시장 현황 3. 세계의 불소 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 유형별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록 ...

글로벌 트렌볼론 에난네이트 시장 2023-2027 : 경구제, 주사제
IRTNTR75740-23 / Technavio / 2023년 6월 / 세계의 트렌볼론 에난네이트 시장 2023-2027 트렌볼론 에난네이트 시장은 2022년부터 2027년까지 1,397만 달러로 성장하며, 예측 기간 동안 3.42%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 트렌볼론 에난네이트 시장의 전반적인 분석, 시장 규모...1. 개요 2. 세계의 트렌볼론 에난네이트 시장 현황 3. 세계의 트렌볼론 에난네이트 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 유형별 시장 분석 7. 용도별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록...

글로벌 스타틴 시장 2023-2027 : 병원, 클리닉, 기타
IRTNTR75841-23 / Technavio / 2023년 7월 / 글로벌 스타틴 시장 2023-2027 스타틴 시장은 2022년에서 2027년까지 26억 7661만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 3.36%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 스타틴 시장에 대한 전반적인 분석,...1. 개요 2. 세계의 스타틴 시장 현황 3. 세계의 스타틴 시장 규모 4. 과거 시장 규모 5. 파이브 포스 분석 6. 최종 용도별 시장 분석 7. 유형별 시장 분석 8. 고객 현황 9. 지역별 분석 10. 추진 요인/과제/동향 11. 기업 현황 12. 기업 분석 13. 부록 ...